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Abstract
Phenotypic tests do not always unequivocally identify some species of viridans group streptococci (VGS). sodA sequence analysis is the
most accurate method for identiﬁcation, although it requires specialized personnel and has not been applied systematically in clinical
microbiology laboratory routines. Matrix-assisted laser desorption ionization-time of ﬂight (MALDI-TOF) is emerging as a rapid alterna-
tive for bacterial identiﬁcation. This study assesses the ability of MALDI-TOF and the API 20 Strep system to identify VGS isolates
recovered from blood cultures using sodA sequence analysis as the reference method. All clinically signiﬁcant VGS isolates recovered
from blood cultures between January 2007 and January 2010 were identiﬁed by sodA sequence analysis and API 20 Strep. The strains
were then tested by MALDI-TOF. Agreement between API 20 Strep/MALDI-TOF and sodA sequence analysis was determined. We
examined 124 clinical isolates. Sensitivities of API 20 strep and MALDI-TOF for the species level identiﬁcation of VGS isolates were,
respectively, as follows: 60.5% and 73.4%. Sensitivities of API 20 strep and MALDI-TOF for the group level identiﬁcation were, respec-
tively, as follows: 70% and 94.3%. The turnaround times to identify VGS isolates by sodA sequence analysis, API 20 Strep and MALDI-
TOF were 12–24, 24–48 h and 15 min, respectively. API 20 Strep cannot accurately identify all isolates of VGS. MALDI-TOF appeared
to be a rapid and reliable alternative for identiﬁcation of VGS strains to group level, but was not able to discriminate closely related
species of certain groups.
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Introduction
Identiﬁcation of viridans group streptococci (VGS) causing
bloodstream infections is important for clinical and epidemi-
ological reasons [1]. As VGS species are genetically related,
it is difﬁcult to identify them using routine biochemical meth-
ods. Therefore, molecular characterization of VGS is manda-
tory for identiﬁcation to species level. Phenotypic methods
such as the API 20 Strep system remain the most widely
used in clinical laboratories; however, 20–30% of strains
cannot be unequivocally identiﬁed to species level, and the
technique does not provide results until 24–48 h after isola-
tion [2,3]. Several nucleic acid–based technologies have been
developed to improve identiﬁcation of VGS. Sequence
analysis of the 16S rRNA gene has been widely applied for
the taxonomy of streptococci, although the ability of this
method to differentiate between closely related species,
particularly Streptococcus oralis and Streptococcus mitis, has
been questioned [4]. The superoxide dismutase gene (sodA)
has a more discriminative target sequence than the 16S
rRNA gene for differentiating between closely related
streptococcal species and is considered the most accu-
rate method for identiﬁcation of VGS to species
level [3–6]. However, sodA sequence analysis is very time-
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consuming, requires specialized personnel, and has not been
applied systematically in clinical microbiology laboratory
routines.
Another recently published approach, multilocus sequence
analysis (MLSA), has proven to be a reliable alternative for
the identiﬁcation of VGS [7]. However, this technique is not
available in most clinical microbiology laboratories and has
not been proven to be superior to the sodA sequence analy-
sis for the speciation of VGS.
In recent years, matrix-assisted laser desorption ioniza-
tion-time of ﬂight (MALDI-TOF) has emerged as a rapid
alternative for bacterial identiﬁcation based on the protein
composition of microbial cells. The few studies that have
analysed identiﬁcation of VGS with this system are limited to
the differentiation of species of certain groups, and most use
sequence analysis of the 16S rRNA gene as a comparator. In
addition, these studies also report that S. mitis group isolates
have been misidentiﬁed as Streptococcus pneumoniae [8–10].
The aim of the present study was to assess the ability of
MALDI-TOF and the API 20 Strep system to identify VGS
isolates recovered from blood cultures using sodA sequence
analysis as the reference method.
Material and Methods
Bacterial strains and cultures
All clinically signiﬁcant VGS isolates recovered from blood
cultures between January 2007 and January 2010 in our insti-
tution were studied. The isolates were subcultured on choc-
olate agar and incubated at 37C in 5% CO2 for 48 h. The
strains were preliminarily identiﬁed as VGS based on a nega-
tive catalase test result, Gram stain (Gram-positive cocci in
chains) and alpha-haemolysis. Optochin and bile solubility
tests were used to rule out pneumococci [11,12]. Bile escu-
lin and sodium chloride were used to rule out enterococci.
The VGS isolates were identiﬁed by sodA sequence analysis
and by the API 20 Strep system and stored at )70C. The
strains were then thawed and subcultured for analysis by
MALDI-TOF.
Reference strains
The reference strains used for quality control were
Streptococcus equinus CECT 213 (ATCC 33317), Streptococcus
mutans CECT 479 (ATCC 25175), Streptococcus pneumoniae
CECT 993 (ATCC 27336), Streptococcus intermedius CECT
803 (ATCC 27335), Streptococcus gordonii CECT 804 (ATCC
33399), Streptococcus salivarius CECT 805 (ATCC 7073),
Streptococcus anginosus CECT 948 (ATCC 12395) and Strepto-
coccus oralis CECT 907 (ATCC 35037).
Phenotypic identiﬁcation
Phenotyping was performed using the API 20 Strep system
(bioMe´rieux, Marcy l¢Etoile, France) following the
manufacturer’s instructions. API 20 strep results were
obtained after 24–48 h of incubation at 35–37C as a
numerical proﬁle obtained from a visual reading, according
to the manufacturer’s recommendations. Strains were identi-
ﬁed using apiweb (https://apiweb.biomerieux.com/) and API
20 StrepV3.0 (bioMe´rieux) and classiﬁed as follows: (i) iso-
lates identiﬁed to species level, (ii) isolates identiﬁed to
genus level and (iii) unidentiﬁed isolates. Identiﬁcation to spe-
cies level was classed as excellent, very good, good and
acceptable.
Genotypic identiﬁcation
DNA extraction. Bacterial DNA was extracted and puriﬁed
using the QIAmp DNA Minikit (Qiagen Ltd, Crawley, UK)
according to the manufacturer’s instructions.
sod gene polymerase chain reaction (PCR)-based sequencing. . An
internal fragment of approximately 480 bp of the sodA gene
was ampliﬁed by PCR using degenerated primers d1 (5¢-
CCITAYICITAYGAYGCIYTIGARCC-3¢) and d2 (5¢-AR-
RTARTAIGCRTGYTCCCAIACRTC-3¢), as previously
described [6]. The amplicons obtained were detected by
electrophoresis through a 1.4% agarose gel in 1· Tris-
borate-EDTA buffer and visualized using ethidium bromide
staining and UV transillumination. After puriﬁcation in a com-
mercial system (High Pure PCR Product Puriﬁcation Kit;
Roche Diagnostics, Mannheim, Germany), PCR products
were subsequently sequenced using the Big Dye Terminator
method according to the manufacturer’s instructions and
detected in an AbiPrism 3100 automatic DNA sequencer
(Applied Biosystems Inc, Foster City, CA, USA). The
sequences obtained were compared with those stored in
GenBank using BLAST alignment software (http://
www.ncbi.nlm.nih.gov/blast) and BIBI (bioinformatics bacterial
identiﬁcation tool: http://pbil.univ-lyon1.fr/bibi). Identiﬁcation
to species level was deﬁned as ‡99% sequence similarity with
only one species of Streptococcus. When the score was
‡95% and <99%, the isolate was assigned to the correspond-
ing genus (Streptococcus spp.)
Matrix-assisted laser desorption ionization-time of ﬂight
mass spectrometry
A small amount of a freshly grown 48-hour-old colony was
inoculated directly onto a ground steel MALDI target plate
in a thin ﬁlm. The ﬁlm was then overlaid with 1 lL of a
saturated solution of a-cyano-4-hydroxycinnamic acid in 50%
acetonitrile-2.5% triﬂuoroacetic acid and allowed to dry at
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room temperature. The plate was inserted into the Micro-
ﬂex MALDI-TOF MS instrument (Bruker Daltonics, Bremen,
Germany). The mass spectra generated were analysed using
the Bruker Biotyper 3.0 software package and compared
with a reference spectra database.
The identiﬁcation criteria used in our analysis, as outlined
by the manufacturer, were as follows: a score of ‡2 indicated
identiﬁcation to species level, a score between 1.7 and 1.9
indicated identiﬁcation to genus level, and a score £1.7 was
interpreted as unreliable identiﬁcation.
Deﬁnitions
Discrepant results were classiﬁed according to the following
deﬁnitions.
Very major discrepancies: the isolate was assigned to a dif-
ferent genus.
Major discrepancies: the isolate was assigned to the same
genus, to a different graph, and to a different species.
Minor discrepancies: the isolate was assigned to a different
species but to the same group.
Results for species level identiﬁcation by MALDI-TOF and
API 20 Strep were considered concordant when identiﬁcation
to species level exactly matched that of the reference method.
Results for group-level identiﬁcation by MALDI-TOF and
API 20 Strep were considered concordant when identiﬁca-
tion to group level exactly matched that of the reference
method.
Statistical analysis
Agreements and validity values were calculated with a 95%
conﬁdence interval based on an exact binomial distribution.
Agreements between the two methods evaluated and the
reference technique were compared using a two-tailed
McNemar test for paired samples. A p-value of <0.05 was
considered statistically signiﬁcant. Data were analysed using
SPSS, version 15.0 (SPSS Inc, Chicago, IL, USA).
Results
We examined 124 clinical isolates from 115 patients (one
strain per episode of bloodstream infection) and eight refer-
ence strains.
Reference strains
The identiﬁcation results of the reference strains obtained
using the three methods are shown in Table 1.
Clinical isolates
sodA sequence analysis identiﬁed all clinical isolates to species
level (‡99% sequence similarity with only one species of
Streptococcus). Identiﬁcation of 124 VGS in blood culture iso-
lates by sodA sequence analysis is shown in Table 2.
The API 20 Strep identiﬁed 93/124 isolates (75%) to species
level. Seventy-six isolates were concordant to species level by
sodA sequence analysis and API 20 Strep (Table 3). In 18 of the
isolates, species identiﬁcation differed between sodA sequence
analysis and API 20 Strep (Table 3). Eight of these 18 isolates
were matched to group level (minor discrepancies). Agree-
ment between API 20 Strep and sodA sequence analysis was
60.5% to species level and 70% to group level (Table 4).
Identiﬁcation to genus level by the API system was
achieved for 19/124 (15.3%) cases; 12/124 (9.6%) isolates
remain unidentiﬁed (Table 3).
Ninety-one isolates were concordant to species level by
sodA sequence analysis and MALDI-TOF, 74 with a score ‡2
and 17 with scores between 1.7 and 1.9. Discrepant results
were obtained in 27 isolates, 16 with a score of ‡2 and 11
with scores between 1.7 and 1.9 (Table 3). Among these
discrepant results, 25 were identical at group level (minor
discrepancies). Agreement in identiﬁcation to species level
and to group level between MALDI-TOF and sodA sequence
analysis was 73.4% and 93.5%, respectively (Table 4). Identiﬁ-
cation was unreliable in 6/124 (4.8%) isolates (score, £1.7).
TABLE 1. Identiﬁcation results for
the reference strains according to
the two techniques evaluated
Reference
strains CECT/ATCC
sodA sequence analysis
(sequence similarity, %) API 20 strep (ID, %)
MALDI-TOF
(score)
S. equinus 213/33317 S. equinus (99) S. bovis II4 (99.9) S. gallolyticus subsp
pasteurianus (1.8)
S. mutans 479/25175 S. mutans (99) S. mutans (99.9) S. mutans (2.3)
S. pneumoniae 993/27336 S. pneumoniae (99) S. pneumoniae (89) S. pneumoniae (2.1)
S. intermedius 803/27335 S. intermedius (99) S. intermedius (92.3) S. intermedius (1.8)
S. gordonii 804/33399 S. gordonii (99) Unreliable identiﬁcation S. gordonii (2.1)
S. salivarius 805/7073 S. salivarius (99) S. salivarius (98.2) S. salivarius (2.1)
S. anginosus 948/12395 S. anginosus (100) S. anginosus (99) S. anginosus (2.1)
S. oralis 907/35037 S. oralis (99) S. oralis (78) S. pneumonie (1.8)
ID, identiﬁcation.
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Incorrect identiﬁcation by the two techniques evaluated
includes minor and major discrepancies (Table 3). No very
major discrepancies were observed.
Sensitivity, speciﬁcity, negative predictive value and posi-
tive predictive value of the two evaluated methods for the
identiﬁcation of VGS isolates are represented in Table 5.
The turnaround times to identify VGS isolates from blood
cultures by sodA sequence analysis, API 20 strep and MALDI-
TOF, were 12–14 h, 24–48 h and 15 min, respectively.
Discussion
Currently, no recognized reference standard technique can
satisfactorily identify many VGS. However, in a large number
TABLE 3. Results of API 20 strep and MALDI-TOF for the identiﬁcation of VGS isolated from blood cultures
API 20 Strep MALDI-TOF
Unreliable
ID
Genus
level ID Concordantb
Discrepantc
Unreliable ID
(score > 1.7)
Concordantb Discrepantc
Major Minor 1.7–1.9 ‡2 Major Minor
S. mitis group 38
S. mitis 7 1 1 5 0 0 0 0 1 6
S. oralis 25 2 4 16 3 0 2 5 10 0 8
S. cristatus 3 3 0 0 2 1 0 0
S. infantis 3 1 1 1 0 2 1 0 0
salivarius group 12
S. salivarius 8 8 0 0 1 1 5 1 0
S. vestibularis 1 1 0 0 0 0 1 0 0
S. infantarius 3 2 1 0 0 1 2 0 0
mutans group 1
S. mutans 1 1 0 0 1 0 0 0
anginosus group 30
S. anginosus 24 3 7 6 2 6 3 2 17 0 2
S. constellatus 6 5 1 0 0 6 0 0
sanguinis group 19
S. sanguis 5 4 1 0 0 5 0 0
S. parasanguis 10 2 7 1 0 1 9 0 0
S. gordonii 4 2 1 0 0 1 0 4 0 0
bovis group 24
S. equinus 9 2 6 0 1 0 0 0 9
S. gallolyticus subsp gallolyticus 5 5 0 0 0 5 0 0
S. gallolyticus subsp pasteurianus 6 5 1 0 0 6 0 0
S. lutetiensis 4 1 1 2 0 0 2 2 0 0
Overall 124 75 10 8 17 74 2 25
ID, identiﬁcation.
asodA sequence analysis was used as the reference method to characterize the strains.
bResults were considered concordant when identiﬁcation by MALDI-TOF/API 20 strep exactly matched identiﬁcation by the sodA gene sequence analysis.
cDiscrepant results include major discrepancies (incorrect genus) and minor discrepancies (correct genus, incorrect species)
TABLE 4. Agreements for each group of VGS in identiﬁcation to species level and group levela
Agreement for identiﬁcation to species level (%) Agreement for identiﬁcation to group level
API MALDI pa API MALDI pb
mitis group (n = 38) 65.8 (48.6–80.4) 55.2 (38.3–71.4) 1 65.8 (48.6–80.4) 92 (78.6–98.3) 0.013
salivarius group (n = 12) 75 (42.8–94.5) 83.3 (51.6–97.9) 1 75 (42.8–94.5) 83.3 (51.6–97.9) 1
mutans group (n = 1) 100 (25–100) 100 (25–100) 1 100 (25–100) 100 (25–100) 1
anginosus group (n = 30) 36.6 (19.9–56.1) 83.3 (65.3–94.4) <0.01 56.6 (37.4–74.5) 83.3 (65.3–94.4) <0.001
sanguinis group (n = 19) 57.9 (33.5–79.7) 100 (82.3–100) 0.008 63 (38.4–83.7) 100 (82.3–100) <0.001
bovis group (n = 24) 75 (53.3–90.2) 62.5 (40.6–81.2) 0.508 79 (57.8–92.9) 62.5 (40.6–81.2) 0.625
Overall (n = 124) 60.5 (51.3–69.1) 73.4 (64.7–80.9) 0.003 70 (57.9–75.2) 93.5 (87.8–97.2) <0.001
aAgreements were calculated with a 95% conﬁdence interval based on an exact binomial distribution.
bp <0.05 was considered statistically signiﬁcant.
TABLE 2. Identiﬁcation of 124 VGS strains isolated from
blood cultures by sodA sequence analysis
Species (sodA sequence analysis) No.
S. mitis 7
S. oralis 25
S. cristatus 3
S. infantis 3
S. salivarius 8
S. vestibularis 1
S. infantarius 3
S. mutans 1
S. anginosus 24
S. constellatus 6
S. sanguis 5
S. parasanguis 10
S. gordonii 4
S. equinus 9
S. gallolyticus subsp gallolyticus 5
S. gallolyticus supsp pasteurianus 6
S. lutetiensis 4
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of works, sodA sequence analysis has proven to be a highly
accurate identiﬁcation tool for characterization of VGS [3–6].
In the present study all clinical isolates of VGS recovered from
blood cultures were identiﬁed to the species level by sodA
sequence analysis. In addition, all reference strains tested were
correctly identiﬁed. Therefore, we used this technique as a
reference method to assess the ability of MALDI-TOF and API
20 strep to identify VGS causing blood stream infections.
Our study demonstrates that MALDI-TOF is more sensi-
tive than API 20 Strep for identiﬁcation of VGS to species
level, except for species belonging to mitis and bovis groups.
MALDI-TOF also shows higher sensitivity for identiﬁcation
of VGS to group level.
All strains that could not be discriminated at any taxo-
nomic level by the API system were assigned to species level
by MALDI-TOF. Agreement to species level between
MALDI-TOF and sodA sequence analysis was better than that
obtained between API 20 strep and sodA sequence analysis
(73.4% vs. 60.5%, p 0.003). MALDI-TOF was also superior in
identifying strains to group level (93.5% vs. 70.3%, p <0.001).
API 20 strep better identiﬁed species belonging to the mitis
and bovis groups, although the differences did not reach sta-
tistical signiﬁcance. Identiﬁcation was unreliable in only in 6/
124 (4.8%) isolates (score £1.7) by MALDI-TOF, whereas
API 20 strep was not able to identify 12/124 (9.6%). No very
major discrepancies were observed with either of the two
techniques. In the case of API 20 strep, 44% of discrepancies
were minor (the isolate was assigned to a different species
but to the same group); with MALDI-TOF, 96% were minor.
We suggest that minor discrepancies can be reported to cli-
nicians as species belonging to a speciﬁc group that is actually
associated with different diseases and patterns of antibiotic
resistance. MALDI-TOF was able to identify 94% of the iso-
lates to group level while the API system was only able to
identify 70% to group level. Previous reports show the poor
sensitivity of API 20 strep and other phenotypic methods for
identiﬁcation of VGS [13,14]. Hoshino et al. [4] reported
50% concordance between API 20 strep and molecular iden-
tiﬁcation of non-haemolytic strains of streptococci. This ﬁnd-
ing is consistent with the results shown in the present study.
Freidrichs et al. [10] compared MALDI-TOF and RAPID-
strep/PCR16s by analysing 99 VGS isolates and 10 reference
strains and demonstrated 100% consistency between
MALDI-TOF and the phenotypic/genotypic identiﬁcation sys-
tem. However, we found that MALDI-TOF was limited in
that it identiﬁed eight isolates of S. oralis and six isolates of
S. mitis as S. pneumoniae. Misidentiﬁcation of S. mitis group
isolates as S. pneumoniae by MALDI-TOF has been reported
elsewhere [8,9]. In our study, we ruled out all pneumococcal
isolates on the basis of the optochin susceptibility test andT
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bile solubility test, both of which proved to be highly
sensitive and speciﬁc for the identiﬁcation of pneumococci
when performed together [11,12]. Moreover, based on this
identiﬁcation scheme, in none of the cases did the reference
standard (sodA sequence analysis) identify as S. pneumoniae
any isolate included in the study as VGS.
Romero et al. [15] reported a limitation of MALDI-TOF
(Bruker) in discriminating the two main S. gallolyticus subspe-
cies, a ﬁnding that differs from our results. We found that ﬁve
isolates of S. gallotyticus subsp gallolyticus and six isolates of
S. gallolyticus subsp pasteurianus were correctly identiﬁed by
MALDI-TOF. However, we also observed that nine isolates of
S. equinus were identiﬁed as S. gallolyticus subsp pasteurianus.
Therefore, we suggest that the database of Bruker technology
(Biotyper 3.0 software package) should be reviewed to resolve
problems associated with identiﬁcation of S. equinus and we
propose reporting these results as members of the S. bovis
group until an appropriate solution has been found.
As for the identiﬁcation scores given by the manufacturer,
we assessed the level of agreement in the score interval pro-
posed for identiﬁcation to genus level (1.7–1.9). We observed
that within this score interval there were 17 concordant results
and 11 discrepant results, that is, 60.7% agreement in this inter-
val score (vs. 82.2% in the ‡2 interval score). Among these 11
discrepancies, eight S. mitiswere misidentiﬁed as S. pneumoniae.
Although this is a limitation of this method, we suggest that VGS
isolates identiﬁed by MALDI-TOF with scores between 1.7 and
1.9 could be correctly identiﬁed. However, if the identiﬁcation
obtained is S. pneumoniae additional tests should be performed.
We also propose the following identiﬁcation scheme for
VGS isolates from blood cultures. First, MALDI-TOF must
be performed in combination with the previously mentioned
tests to rule out pneumococci and enable identiﬁcation of
VGS to group level in 94% of isolates with 73% concordance
to species level. If the score by this technique is <1.7, which
in our experience occurs in 5% of cases, sodA sequence anal-
ysis should be performed.
In conclusion, our data show that API 20 strep does not
accurately identify all isolates of VGS causing bloodstream
infections. MALDI-TOF appears to be a rapid and reliable
alternative for group-level identiﬁcation of VGS isolated from
blood cultures, although it is not able to discriminate geneti-
cally related species of certain groups and can misidentify
S. mitis and S. oralis isolates as S. pneumoniae.
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